Form 8-K - Current report:
SEC Accession No. 0001193125-24-180754
Filing Date
2024-07-18
Accepted
2024-07-18 08:10:57
Documents
15
Period of Report
2024-07-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d744813d8k.htm   iXBRL 8-K 38520
2 EX-99.1 d744813dex991.htm EX-99.1 15996
  Complete submission text file 0001193125-24-180754.txt   227143

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nams-20240716.xsd EX-101.SCH 3568
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20240716_def.xml EX-101.DEF 14183
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20240716_lab.xml EX-101.LAB 23099
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20240716_pre.xml EX-101.PRE 15031
17 EXTRACTED XBRL INSTANCE DOCUMENT d744813d8k_htm.xml XML 5857
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 241123735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)